The Christie NHS Foundation Trust The Role of Critical Care for Non- Haematological Malignancy Dr Phil Haji-Michael

The Christie NHS Foundation Trust

The Role of Critical Care for Non-Haematological

Malignancy

Dr Phil Haji-Michael


Mr Onc.

Mr Heam.


The “patient journey” & Cancer

1) Long time to an anticipated poor outcome

2) Relatively well until a final decline

3) May well have discussed last wishes with their family

4) Palliative care planning and hospice care

Murray SA et al. BMJ 2005;330:1007-11.


Conflict with oncologists


Changing outcomes for cancer



For some cancers the natural history is becoming more like a chronic relapsing remitting disease


For some cancers things are little changed


Is survival alone the most important issue?


Issues for oncology patients in critical care

• The individual patient’s journey not the cohort• How reversible is the acute condition• Is the current problem treatment related?• How much benefit for how much harm?• Decision making and who to talk to


Changes in critical care

• The impact of outreach (“upstream triage”)

• Newer technologies available

Ventilators, NIV & cardiovascular monitoring

• Standardisation of care

Sepsis & ventilator care bundles


Bigger issues…..

1) Availability of beds• Who do you pick & how do you judge?

Metastatic cancer vs emergency AAA

2) Financial austerity & the NHS• Cancer drugs versus hip replacements

3) Demographics• Ageing population & they are not dying from

myocardial infarcts anymore

4) Acute Oncology• Only 10% of “acute oncology” is treatment related


Scenarios


How to use your Handset

Please ensure that your handset is switched on

and active



Use the keypad buttons to select your choice/choices. The keypad supports numeric and alphanumeric



The Screen will illuminate for a few seconds when voting begins

Once you have voted it will say ‘received’ on

the screen


What did you think of Lunch?

1) Good

2) Poor

3) Fantastic

4) Unedible

83%

10%2

17%

30%4


Case 1: 57yr woman with Myeloma

Disease for 4 yr, now on 3rd line treatment

Known recent vertebral fracture

Now increasingly short of breath & febrile over

past 3 days

Seen by oncology registrar in clinic and admitted

to the ward. He writes “For everything” in the notes.


Case 1: 57yr woman with Myeloma

Breathless at rest T 38.5˚C

RR 25 BVM@ 15 l/min SaO2 85%

Crepitataions in both bases

HR120 BP 90/50 CRT 4 sec

PU’d 8hr ago,

ABG pH 7.3 PO2 6 kPa PCO2 3.3 kPa BE -6

Urea 15 Creat 200


Q1. Would you…

1) Admit for full level 3 care?

2) Admit for level 2 care only?

3) Limit to ward care only (level 1)?

4) Put on the end of life pathway?

5) Ring up, berate the Oncology

SpR and refuse to come and see

the patient?

40%

1

52%

20%3

2%

4

5%

5


Q2. Likely mortality? (hospital discharge)

1) 100%

2) 80%

3) 60%

4) 40%

5) 20%

0%1

41%

2

30%

3

23%

4

7%

5


Case 2: 64yr woman with NHL

Stage IV B cell lymphoma 2yr agoIn remission but recently noticed parotid lumpMRI scan - tumor in parotid infiltrating left temporallobe

Attended for chemo, SpR noticed AF. Echo shows“thrombus in RA”. Admitted from clinic. Now (18:00 Friday) sudden deterioration & a call tooutreach…


Case 2: 64yr woman with NHL

Acutely unwell, clammy, breathless

RR 30 SaO2 83% on air Chest clear

HR 65 BP 90/50 CRT 3 sec

New systolic murmur 3/6

ABG pH 7.48 pO2 8.55kPa pCO2 3.5kPa BE -2


Q3. The immediate plan would be..

1) Chemotherapy

2) Thrombolysis

3) Anticoagulation

4) Surgery (Thrombectomy)

5) More imaging (e.g. CT scan

chest)

5%

1

24%

2

29%

3

14%

4

29%

5


Q4. Would you…





1 47.6%

2 31.0%

3 14.3%

4 7.1%



Case 3: 43yr woman Breast CA

Lumpectomy 5yr,

Local recurrence 4yr, mastectomy, node clearance

& local radiotherapy, and chemo (FEC)x6

1yr boney mets, now on Herceptin

Last 24hrs, developed fever, cough & felt unwell.

Presented to local A&E


Case 3: 43yr woman Breast CA

In resus: Given O2 & 2 litres saline

Flushed and unwell. T 39˚C

RR 20 SaO2 95% 35%FiO2

Right basal signs

HR120 BP 75/40 CRT <2secs feels warm

Hickman in situ

ABG pH 7.3 pO2 9.6kPa pCO2 3.3kPa BE -6


Q5. What would you give for initial management of the circulation

1) No drugs, just more fluids

2) Norepinephrine

3) Epinephrine

4) Dobutamine

5) Cardiac output monitoring & then

decide

39%

1

27%

20%3

2%

4

32%

5


Q6. Would you…





1 65.9%

2 27.3%

3 4.6%

4 2.3%


Q7. Likely mortality? (hospital discharge)1) 100%

2) 80%

3) 60%

4) 40%

5) 20%

0%1

9%

2

26%

3

53%

4

12%

5


Case 4: 74 yr man with Lung CA

Non-small cell lung cancer diagnosed 5months

ago. Smoker 40 pack years.

On radical radiotherapy (now at 16/20)

Admitted to the ward not coping, difficulty swallowing &

productive cough

Increasingly short of breath

On fentanyl patches for pain, increased on admission

Deteriorates over 48hr, now drowsy and low sats..


Case 4: 74 yr man with Lung CA

Unwell T37.5˚CRR 30 SaO2 85% on 24% OxygenBronchial breathing and crepitations on right baseHR 120 BP 110/60 CRT < 2 secsDrowsy and only responsive to pain. Small pupils.

Already on antibiotics for his “chest”ABG pH 7.28 pCO2 7.8kPa pO2 8.8kPa BE -1


Q8. Would you…





1 14.0%

2 16.3%

3 32.6%

4 37.2%


Summary

Cancer is a very heterogeneous group of diseasesOutcome has changed radically for some over thepast few decadesEqually critical care has undergone a similartransformationOpen and honest dialogue between Oncology andCritical Care is essentialUpstream/ward assessment and triage is also key“How much harm for how much benefit”


Thank you

Documents

The Christie NHS Foundation Trust The Role of Critical Care for Non- Haematological Malignancy Dr Phil Haji-Michael